SNSE - Sensei Biotherapeutics Inc
29.5
-0.500 -1.695%
Share volume: 165,001
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$30.00
-0.50
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-14-2024 | 03-28-2025 | 05-06-2025 | 11-14-2025 | |
| Cash flow financing | -209.000 K | -180.000 K | -204.000 K | -194.000 K | -214.000 K | -152.000 K | |
| Other financing cash flows | -209.000 K | -180.000 K | -204.000 K | -194.000 K | -214.000 K | -152.000 K | |
| Cash flow | -2.055 M | 935.000 K | 7.240 M | -9.137 M | -117.000 K | -1.995 M | |
| Net income | -7.992 M | -7.142 M | -7.253 M | -7.770 M | -6.864 M | -4.569 M | |
| Depreciation | 137.000 K | 135.000 K | 140.000 K | 139.000 K | 30.000 K | 30.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 5.770 M | 6.907 M | 12.914 M | -3.151 M | 7.191 M | 1.743 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 37.000 K | 109.000 K | 0.000 | 0.000 | -40.000 K | 0.000 | |
| Cash Change | -2.055 M | 935.000 K | 7.240 M | -9.137 M | -117.000 K | -1.995 M |